Sulfabenzamide 184 mg / sulfacetamide sodium 144 mg / sulfathiazole 172 mg [Sultrin Triple Sulfa]
RxNorm 1012230
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1012230 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sulfabenzamide 184 mg / sulfacetamide sodium 144 mg / sulfathiazole 172 mg [Sultrin Triple Sulfa].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDC